First AF Patients Treated With Farapulse Pulsed Field Ablation System
Diagnostic and Interventional Cardiology,
March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S.
March 3, 2021 — Farapulse Inc. announced the first patients were treated in the ADVENT Trial, a U.S.
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
FARAPULSE's Pivotal ADVENT Trial underway with First Patients Treated with its Breakthrough Pulsed Field Ablation System to…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pioneering technology has demonstrated potential to improve safety for patients with paroxysmal atrial fibrillation and…
Pulsed field ablation (PFA) targeting areas beyond the pulmonary vein appeared to provide short-term lesion control without…
NATIONAL HARBOR, MD. – Cardiac electrophysiologists have reported using pulsed field ablation, a new power source for catheter…
En mer skonsam och snabbare metod för att isolera elektriska signaler i hjärtat, lyfts fram som en av höjdpunkterna inom arytmi…
SOURCE FARAPULSE Inc. Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's…
SOURCE FARAPULSE Inc. Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's…
SOURCE FARAPULSE Inc. Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…
Late Breaking Clinical Trial Presentation and concurrent JACC publication highlight FARAPULSE technology's potential to achieve…